BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16557102)

  • 1. Do serum and red blood cell folate levels indicate iron response in hemodialysis patients?
    Mitsopoulos E; Zanos S; Ginikopoulou E; Tsiatsiou M; Giannakou A; Pavlitou A; Sakellariou G
    ASAIO J; 2006; 52(2):163-8. PubMed ID: 16557102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum ferritin and iron therapy in patients treated with periodic hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G; Mosconi G; Baldrati L
    Quad Sclavo Diagn; 1982 Dec; 18(4):454-62. PubMed ID: 7186648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review of the newer intravenous iron therapy options.
    Edwards JH
    Nephrol Nurs J; 2003 Feb; 30(1):70-3. PubMed ID: 12674953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
    Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
    Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
    Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of folate and cobalamin are lower in depressed than in nondepressed hemodialysis subjects.
    Clement L; Boylan M; Miller VG; Rockwell M; Allred K
    J Ren Nutr; 2007 Sep; 17(5):343-9. PubMed ID: 17720104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Issues related to iron replacement in dialyzed patients].
    Kessler M
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
    Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
    Chełchowska M; Laskowska-Klita T; Leibschang J
    Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.